Read + Share
Amedeo Smart
Independent Medical Education
Sponseiler I, Bandian AM, Pusic P, Lion T, et al. Combinatorial treatment options for highly resistant compound mutations in the kinase domain of the BCR::ABL1 fusion gene in Ph-positive leukemias. Am J Hematol 2024;99:E9-E11.PMID: 38085116
Email
LinkedIn
Facebook
Twitter
Privacy Policy